AHAleksander Moldt Haack

Aleksander Moldt Haack

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksander Moldt Haack has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mapping Tissue-Specific Protease Dynamics in the Pig Respiratory Tract During Influenza A Virus Infection

    by Chrysillis Hellemann Polhaus, Aleksander Moldt Haack, Ramona Trebbien, Lars Erik Larsen, Ulrich Auf Dem Keller, Kerstin Skovgaard, Konstantinos Kalogeropoulos

    Influenza A virus (IAV) is a zoonotic pathogen capable of infecting diverse avian and mammalian hosts, causing seasonal epidemics and occasional global pandemics in humans. Viral entry requires proteolytic activation of hemagglutinin (HA). While serine proteases such as TMPRSS2, and HAT are known HA activators, the respiratory tract harbours additional proteases whose contributions to infection remain unclear. Dysregulation of these proteases can enhance viral replication, tissue damage, and inflammation, highlighting the need for a systems-level view of the proteolytic landscape. Here, we use high-throughput, proteome-wide proteomics and N-terminomics to identify 112 host proteases across the nasal mucosa, trachea, and lung. We monitor and validate 28 proteases with targeted proteomics and microfluidic qPCR, representing a comprehensive degradome analysis in the respiratory tract of the highly translational pig model of influenza infection. We show that protease abundance and activity were highly tissue-specific: while the nasal mucosa showed selective activation of broad- and narrow-specificity proteases alongside robust antiviral responses, the trachea exhibited modest modulation with subtle shifts in protease–inhibitor balance, and the lung maintained predominantly active proteases despite lower viral loads but severe tissue damage, indicative of immune-mediated pathology. Sequence motif analysis revealed distinct cleavage preferences across tissues, indicating differential protease processing across the studied respiratory tissues in antiviral pathways, antigen processing, and tissue remodelling. Several identified proteases, including ST14, KLKB1, PRSS8, and LGMN, were increased and functionally active upon infection, suggesting roles in viral processing and host immune regulation. Collectively, our results define a spatially organised proteolytic network that shapes tissue-specific antiviral host responses and contributes to H1N1 influenza pathogenesis.

  • Open Access

    Extracellular matrix alterations in inflammatory skin diseases: emerging biomarkers and clinical implications

    by Helena Port, Matej Andelic, Alexander Nyström, Aleksander Moldt Haack, Konstantinos Kalogeropoulos, Valdemar Wendelboe Nielsen, Antonius Pieter Van Den Heuvel, Asger Reinstrup Bihlet, Simon Francis Thomsen, Signe Holm Nielsen

    The interaction among extracellular matrix (ECM) components (proteoglycans, elastin, laminins, collagens and metalloproteinases) is important for maintaining homeostasis of the skin. However, in chronic inflammatory diseases, tissue homeostasis is disrupted by having an uncontrolled remodelling of the ECM, resulting in an imbalance of its composition and functionality. In these pathologies, there is a dysregulation of the immune system characterized by recurrent itching, pain and inflammation in affected areas of the skin. Three of the most common inflammatory skin diseases are hidradenitis suppurativa, psoriasis and atopic dermatitis, with worldwide prevalence of 1%, 3% and 15%, respectively. The shared pathological characteristic for these diseases is an altered skin tissue structure, characterized by an excessive remodelling of ECM proteins. Despite well-documented evidence of ECM alterations in these pathologies, biomarkers reflecting ECM remodelling to aid drug development and potential treatment targets have been overlooked. There is therefore an unmet need to develop biomarkers for predicting outcomes and selecting treatment for individual patients. This review focuses on ECM dysregulation in inflammatory skin diseases, with a focus on how biomarkers can predict outcomes and monitor drug efficacy.


  • Open Access

    High-Throughput and High-Sensitivity Biomarker Monitoring in Body Fluid by Fast LC SureQuant IS-Targeted Quantitation

    by Konstantinos Kalogeropoulos, Simonas Savickas, Aleksander M. Haack, Cathrine A. Larsen, Jacek Mikosiński, Erwin M. Schoof, Hans Smola, Louise Bundgaard, Ulrich Auf Dem Keller


  • Open Access

    CLIPPER 2.0: Peptide-Level Annotation and Data Analysis for Positional Proteomics

    by Konstantinos Kalogeropoulos, Aleksander Moldt Haack, Elizabeta Madzharova, Antea Di Lorenzo, Rawad Hanna, Erwin M. Schoof, Ulrich Auf Dem Keller


  • Open Access

    CLIPPER 2.0: Peptide level annotation and data analysis for positional proteomics

    by Konstantinos Kalogeropoulos, Aleksander Moldt Haack, Elizabeta Madzharova, Antea Di Lorenzo, Rawad Hanna, Erwin M. Schoof, Ulrich Auf Dem Keller

    Positional proteomics methodologies have transformed protease research, and have brought mass spectrometry (MS)-based degradomics studies to the forefront of protease characterization and system-wide interrogation of protease signaling. Considerable advancements in sensitivity and throughput of liquid chromatography (LC)-MS/MS instrumentation enable generation of enormous positional proteomics datasets of natural and protein termini and neo-termini of cleaved protease substrates. However, such progress has not been observed to the same extent in data analysis and post-processing steps, which arguably constitute the largest bottleneck in positional proteomics workflows. Here, we present a computational tool, CLIPPER 2.0, that builds on prior algorithms developed for MS-based protein termini analysis, facilitating peptide level annotation and data analysis. CLIPPER 2.0 can be used with several sample preparation workflows and proteomics search algorithms, and enables fast and automated database information retrieval, statistical and network analysis, as well as visualization of terminomic datasets. We demonstrate our tool by analyzing GluC and MMP9 cleavages in HeLa lysates. CLIPPER 2.0 is available at https://github.com/UadKLab/CLIPPER-2.0 .


  • Open Access

    Prototyping of a lateral flow assay based on monoclonal antibodies for detection of Bothrops venoms

    by Cecilie Knudsen, Jonas A. Jürgensen, Pelle D. Knudsen, Irina Oganesyan, Julian A. Harrison, Søren H. Dam, Aleksander M. Haack, Rasmus U.W. Friis, Lars Vitved, Selma B. Belfakir, et al.


  • Open Access

    Prototyping of a lateral flow assay based on monoclonal antibodies for detection of Bothrops venoms

    by Cecilie Knudsen, Jonas A. Jürgensen, Pelle D. Knudsen, Irina Oganesyan, Julian A. Harrison, Søren H. Dam, Aleksander M. Haack, Rasmus U. W. Friis, Selma B. Belfakir, Georgina M. S. Ross, et al.

    Background: Brazil is home to a multitude of venomous snakes, perhaps the most medically relevant of which belong to the Bothrops genus. Bothrops spp . are responsible for roughly 70% of all snakebites in Brazil, and envenomings caused by their bites can be treated with three types of antivenom: bothropic antivenom, bothro-lachetic antivenom, and bothro-crotalic antivenom. The choice in antivenom that is administered depends not only on its availability and how certain the treating physician is that the patient was bitten by a bothropic snake. The diagnosis of a bothropic envenoming can be made based on expert identification of a photo of the snake or based on a syndromic approach wherein the clinician examines the patient for characteristic manifestations of envenoming. This approach can be very effective but requires staff that has been trained in clinical snakebite management, which, unfortunately, far from all relevant staff has. Results: In this paper, we describe a prototype of the first lateral flow assay (LFA) capable of detecting venoms from Brazilian Bothrops spp . The monoclonal antibodies for the assay were generated using hybridoma technology and screened in sandwich enzyme-linked immunosorbent assays (ELISAs) to identify Bothrops spp . specific antibody sandwich pairs. The sandwich pairs were used to develop a prototype LFA that was able to detect venom from several different Bothrops spp . The limit of detection (LoD) of the prototype was evaluated using Brazilian B. atrox whole venom and was determined to be 8.0 ng/mL in spiked serum samples and 9.5 ng/mL in spiked urine samples, when using a portable reader, and < 25 ng/mL in spiked buffer when reading by eye. Significance: The work presented here serves as a proof of concept of a genus-specific venom detection kit, which could support physicians in diagnosing Bothrops envenomings. Although further optimization and testing is needed before the LFA can find clinical use, such a device could aid in decentralizing antivenoms in the Brazilian Amazon and help ensure optimal snakebite management for even more victims of this highly neglected disease.

  • High-throughput and high-sensitivity biomarker monitoring in body fluid by FAIMS-enhanced fast LC SureQuant™ IS targeted quantitation

    by Konstantinos Kalogeropoulos, Simonas Savickas, Aleksander M. Haack, Cathrine A. Larsen, Jacek Mikosiński, Erwin M. Schoof, Hans Smola, Louise Bundgaard, Ulrich Auf Dem Keller


  • Open Access

    High-throughput and high-sensitivity biomarker monitoring in body fluid by FAIMS-enhanced fast LC SureQuant™ IS targeted quantitation

    by Konstantinos Kalogeropoulos, Simonas Savickas, Aleksander M. Haack, Cathrine A. Larsen, Jacek Mikosiński, Erwin M. Schoof, Hans Smola, Louise Bundgaard, Ulrich Auf Dem Keller

    The authors have withdrawn their manuscript whilst they perform additional analyses to test some of their conclusions further. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author ( uadk@dtu.dk ).